2025year

2025年

2020年 2021年 2022年 2023年 2024年

2025年 論文

Data collaboration for causal inference from limited medical testing and medication data.
Nakayama T, Kawamata Y, Toyoda A, Imakura A, Kagawa R, Sanuki M,Tsunoda R, Yamagata K, Sakurai T, Okada Y.
Scientific Reports.(2025)

The effect of Rosmarinus officinalis L infusion supplementation on blood pressure among healthy volunteers and grade 1 hypertensive patients.
Sassi A, Laouani A, Abdessalem MAB, Jarray I, Nasrallah H, Ferdousi F, Nouira M, Mtiraoui A, Mahdhaoui A, Isoda H, Saguem S.
Phytomedicine Plus.(2025)

Isorhamnetin exerts anti-proliferative effect on cancer-associated fibroblasts by inducing cell cycle arrest.
Ganbold M, Louphrasitthiphol P, Miyamoto T, Miyazaki Y, Oda T, Tominaga K, Isoda H.
Biomedicine & Pharmacotherapy.(2025)

自己組織化抗酸化ナノ粒子による 新規臓器保護法の開発.
高橋 一広; 長崎幸夫; 杉 朋幸; 金 在檉; 古屋 欽司; 中橋 宏充; 丸島愛樹; 小田 竜也.
Organ Biology.(2025)

Image-based generation for molecule design with SketchMol.
Wang Z, Chen Y,Ma P, Zhou Yu, Wang J, Liu Y, Ye X, Sakurai T, Zeng X.
Nature Machine Intelligence.(2025)

Impact of lymph node dissection during surgery on the efficacy of pembrolizumab in patients with metastatic urothelial carcinoma.
Kanno T, Ito K, Kita Y, Mochizuki T, Sano T, Yokomizo A, Abe T, Tsuchihashi K, Tatarano S, Inokuchi J, Takahashi A, Matsui Y, Nishiyama H, Kitamura H, Saito R, Kobayashi T; Japan Urological Oncology Group.
Int J Urol.(2025)

Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy.
Hara S, Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kimura T; Japan Urological Oncology Group.
Int J Urol.(2025)

Variations in the diagnostic performance of transurethral resection of bladder tumor with photodynamic diagnosis according to surgical experience: A retrospective, single-center study.
Suzuki S, Nagumo Y, Kojo K, Ikeda A, Isoda B, Yamaguchi A, Tanuma K, Nitta S, Shiga M, Kawahara T, Kandori S, Hoshi A, Negoro H, Mathis BJ, Nishiyama H.
Photodiagnosis and Photodynamic Therapy.(2025)

Feasibility of enzalutamide on patients with recurrent non-muscle-invasive bladder cancer with marker tumors: phase I study.
Kawahara T, Kandori S, Kojima T, Mathis BJ, Shiga M, Nishiyama H.
BMC Res Notes.(2025)

Current Landscape of Adoptive Cell Therapy and Challenge to Develop “Off-The-Shelf” Therapy for Hepatocellular Carcinoma.
Shin SK, Mishima Y, Lee Y, Kwon OS, Kim JH, Kim YS, Kaneko S.
Journal of Gastroenterology and Hepatology.(2025)

Integrating Biological Language Processing and Memory Attention Model for Protein-DNA Binding Residue Prediction.
Guan S, Ye X, Sakurai T.
IEEE International Conference on Bioinformatics and Biomedicine (BIBM).(2025)

Selecting interpretable features for cancer subtyping on multi-omics data.
Shi T,i Ye X, Huang D, Sakurai T.
IEEE International Conference on Bioinformatics and Biomedicine (BIBM).(2025)

Development of chimeric antigen receptor T cells targeting cancer-expressing podocalyxin.
Mishima Y, Okada S, Ishikawa A,Wang B, Waseda M, Kaneko MK, Kato Y, Kaneko S.
Regenerative Therapy.(2025)

Combined Molecular Subclass and Immune Phenotype Correlate to Atezolizumab Plus Radiation Therapy Response in Invasive Bladder Cancer: BPT-ART Phase 2 Study.
Nagumo Y, Hattori K, Kimura T, Sekino Y, Naiki T, Kobayashi Y, Matsumoto T, Osawa T, Kita Y, Takemura M, Mathis BJ, Suzuki S, Tsuzuki T, Ishikawa H, Nishiyama H.
International Journal of Radiation Oncology*Biology*Physics.(2025)